NCT05038124 A Study of Stereotactic Body Radiotherapy (SBRT) and Surgical Stabilization for People With Cancer That Has Spread to the Bone Status ACTIVE_NOT_RECRUITING Phase NA
NCT05036681 A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma Status TERMINATED Phase PHASE2
NCT05032092 Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05010629 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05010031 A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change Status RECRUITING Phase PHASE2
NCT05007613 Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT04991480 A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT04989725 Stereotactic Ablative Radiotherapy for Oligo-Progressive Disease REfractory to Systemic Therapy in Metastatic Cancer Status RECRUITING Phase PHASE2
NCT04975256 Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) Status TERMINATED Phase PHASE1
NCT04931420 Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels Status WITHDRAWN Phase PHASE2
NCT04920747 Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients Status COMPLETED Phase N/A
NCT04906733 Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients. Status UNKNOWN Phase N/A
NCT04900818 Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT04896099 Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial Status COMPLETED Phase N/A
NCT04895046 Maintenance Niraparib and Dostarlimab in Advanced Cholangiocarcinoma Status WITHDRAWN Phase PHASE2
NCT04868773 Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy Status COMPLETED Phase PHASE1
NCT04862260 Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1